In vivo growth inhibition of human colon carcinoma cells (HT-29) by all-trans-retinoic acid, difluoromethylornithine, and colon mitosis inhibitor, individually and in combination

Anticancer Research

Volumn 20, Issue 5 B, 2000, Pages 3485-3489

  Paulsen, J E ^a   Lutzow Holm, C ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Colon cancer; Colon mitosis inhibitor; Difluoromethylornithine; In vivo; Retinoic acid

Indexed keywords

COLON MITOSIS INHIBITOR; EFLORNITHINE; PYROGLUTAMYLHISTIDYLGLYCINE; RETINOIC ACID; TRIPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CELL STRAIN HT29; COLON CARCINOMA; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY WEIGHT; CELL DIVISION; COLONIC NEOPLASMS; DRUG SYNERGISM; EFLORNITHINE; GROWTH INHIBITORS; HT29 CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; OLIGOPEPTIDES; PYRROLIDONECARBOXYLIC ACID; TRETINOIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0033637790     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Role of retinoids in differentiation and carcinogenesis
2. Effects of 13-cisretinoic acid on tumor prevention, tumor growth, and metastasis in experimental colon cancer
3. Effects of all-trans retinoic acid as a potential chemopreventive agent on the formation of azoxymethane-induced aberrant crypt foci: Differential expression of c-myc and c-fos mRNA and protein
4. Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiating agents in the rat colon
5. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs
6. Comparison of the tyrosine kinase activity with the proliferation rate in human colon solid tumors and tumor cell lines
7. The effect of sodium butyrate and retinoic acid on growth and CEA production in a series of human colorectal tumor cell lines representing different states of differentiation
8. Comparison of the antiproliferative effects of transforming growth factor-β, N,N,-dimRizzino ethylformamide and retinoic acid on a human colon carcinoma cell line
9. Antiproliferative activity of retinoic acid and some novel retinoid derivatives in breast and colorectal cancer cell lines of human orgin
10. Polyamine metabolism and its importance in neoplastic growth and as target for chemotherapy
11. Polyamines: From molecular biology to clinical applications
12. Reduced growth rate of dimethylhydrazine-induced colon tumors in rats
13. Influence of gastrin, gastrin receptor blockers, epidermal growth factor, and difluoromethylornithine on the growth and the activity of ornithine decarboxylase of colonic carcinoma cells
14. In vitro response of a human colon tumor xenograft and a lung adenocarcinoma cell line to α-difluoromethylornithine alone and in combination with 5-fluorouracil and doxorubicin
15. Effects of gastrin and difluoromethylornithine on growth of human colon cancer
16. Inhibition by polyamine biosynthesis inhibitor DFMO of the growth of transplanted human colon cancer in nude mice
17. a-Difluoromethylornithine inhibits liver metastasis produced by intrasplenic injection of human tumor cells into nude mice
18. Development of difluoromethylornithine (DFMO) as a chemopreventive agent
19. Purification and characterization of a mitosis inhibiting tripeptide from mouse intestinal extracts
20. An endogenous colon mitosis inhibitor reduces proliferation of colon carcinoma cells (HT-29) in serum-restricted medium
21. The synthetic colon peptide pyroGlu-His-GlyOH inhibits growth of human colon carcinoma cells (HT-29) transplanted subcutaneously into athymic mice
22. Growth-inhibiting N-substituted endogenous peptides
23. Chemoprevention of cancer
24. In vitro and in vivo growth of SC.M1 gastric cells by retinoic acid
25. Synergistic antitumor effect of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo
26. Chemoprevention efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos
27. Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon
28. Influence of indomethacin and difluoromethylornithine on human tumour growth in nude mice
29. Selenium and difluoromethylornithine additively inhibit DMH-induced didtal colon tumor formation in rats fed a fiber-free diet
30. Retinoic acid and difluoromethylornithine inhibit the growth of human colon carcinoma cells (HT-29) in vitro and in vivo
31. Treatment with chemopreventive agents, dimethylornithine and retinyl acetate, results in altered mammary extracellularmatrix
32. Induction of retinoic acid receptor beta mediates growth inhibition in retinoid resistant human colon carcinoma cells
33. Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associated with the induction of retinoic acid receptor beta
34. Modulation by dietary factors in murine FAP models
35. Apoptosis and APC in colorectal tumorigenesis
36. Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways